BioMed Research International

BioMed Research International / 2015 / Article

Research Article | Open Access

Volume 2015 |Article ID 732573 | 9 pages | https://doi.org/10.1155/2015/732573

Development of a Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Trichosporon asahii in Experimental and Clinical Samples

Academic Editor: Mansour El-Matbouli
Received18 Sep 2014
Accepted02 Jan 2015
Published27 Jan 2015

Abstract

Invasive trichosporonosis is a deep mycosis found mainly in immunocompromised hosts, and the major pathogen is Trichosporon asahii. We detected the species-specific intergenic spacers (IGS) of rRNA gene of T. asahii using a loop-mediated isothermal amplification (LAMP) assay in 15 isolates with 3 different visualization methods, including SYBR green detection, gel electrophoresis, and turbidimetric methods. The LAMP assay displayed superior rapidity to other traditional methods in the detection time; that is, only 1 h was needed for detection and identification of the pathogen DNA. Furthermore, the detection limit of the LAMP assay was more sensitive than the PCR assay. We also successfully detect the presence of T. asahii in samples from experimentally infected mice and samples from patients with invasive trichosporonosis caused by T. asahii, suggesting that this method may become useful in clinical applications in the near future.

1. Introduction

Trichosporon asahii (T. asahii) is a type of anamorphic basidiomycetous yeast that exists widely in natural conditions [1, 2]. It can cause many human diseases, such as superficial infections [2, 3], summer-type hypersensitivity pneumonitis [4, 5], and invasive infections [69]. T. asahii belongs to the genus Trichosporon, which contains approximately 50 species of basidiomycetous yeasts, which have been detected in the skin and in the gastrointestinal, respiratory, and urinary tracts of humans and can cause superficial infections in immunocompetent individuals, such as white piedra infections of the hair shaft. Trichosporon species, especially T. asahii, can also cause invasive trichosporonosis in immunocompromised individuals and critically ill patients in the ICU, resulting in high mortality rates (50–80%) [1013]. The genus Trichosporon was the third most commonly isolated non-Candida yeast from clinical specimens in the ARTEMIS DISK global antifungal surveillance study [14] and was the second most common cause of yeast fungemia in patients with hematological malignancies, after Candida species [10, 11].

Early detection of the agent of invasive trichosporonosis is critical for prompt and effective treatment [10, 11]; this is difficult in resource-limited settings without essential diagnostic facilities [15]. At present, a proven diagnosis of invasive trichosporonosis depends on the sterile culture of fungus from body fluids or other related tissue samples and subsequent identification by microscope and biochemical assay [10, 15, 16]. Furthermore, Trichosporon asahii, the most common cause of disseminated trichosporonosis, may be easily mistaken for Candida spp. and other trichosponron strains in culture, especially if mixed yeast or mold species are recovered [17, 18]. Based on morphological characteristics and biochemical profiling, methods for identifying Trichosporon isolates at the species level are time consuming, requiring specialist training and appropriate laboratory facilities, and may yield inconsistent results [17].

Molecular tests for rapid and specific identification of the medically relevant Trichosporon species were developed [19]. The technique incorporates PCR primers designed from DNA sequences within the conserved regions of the rRNA exons and amplifies variable sequences found in the internal transcribed spacer (ITS) and intergenic spacer (IGS) regions of the tandemly repeated 18S, 5.8S, and 26S fungal rRNA and the D1/D2 region of the 26S rRNA gene. Xiao et al. applied reverse line blot (RLB) hybridization and rolling circle amplification (RCA) assays based on the ITS region for the identification of Trichosporon species [20]. However, there is limited information about the clinical molecular detection and identification of T. asahii strains to discriminate it from other clinically important fungal pathogens.

As a result of the rapid development of molecular biology methods, a new identification technique based on polymerase chain reaction (PCR) technology has been widely described. Notomi et al. reported a new DNA loop-mediated amplification (LAMP) method [21]. It can be used to amplify specific target DNA sequences with high sensitivity, and the amplification can be obtained in approximately 60 min with four specific primers and strand displacement DNA polymerase in isothermal conditions (approximately 65°C), eliminating the need for a thermal cycler. The LAMP assay has been reported to be highly specific, sensitive, rapid, and cost-effective [22, 23]. In addition, the LAMP assay could be carried out in a typical laboratory using a water bath or a heating block. It is a potentially valuable means for clinical sample testing. To facilitate the rapid and inexpensive molecular diagnosis of T. asahii, we developed a LAMP assay targeting the IGS1 region and evaluate this assay by using T. asahii-positive clinical samples.

2. Materials and Methods

2.1. Strains and Culture Conditions

In total, 15 Trichosporon asahii strains, 14 other trichosponron strains, and 23 reference strains of related melanized fungi (Table 1) were used to establish the specificity of the LAMP assay.


SpeciesStrains or source

Trichosporon asahii CBS 2479
Trichosporon asahii CBS 8904
Trichosporon asahii CBS 7137
Trichosporon asahii BZ701, Clinical isolates, Hubei, China
Trichosporon asahii BZ702, Clinical isolates, Hubei, China
Trichosporon asahii BZ703, Clinical isolates, Beijing, China
Trichosporon asahii BZ704, Clinical isolates, Guangdong, China
Trichosporon asahii BZ705, Clinical isolates, Shandong, China
Trichosporon asahii BZ706, Clinical isolates, Shanghai, China
Trichosporon asahii BZ707, Clinical isolates, Shanghai, China
Trichosporon asahii BZ708, Clinical isolates, Shanghai, China
Trichosporon asahii BZ709, Clinical isolates, Shanghai, China
Trichosporon asahii BZ710, Clinical isolates, Shanghai, China
Trichosporon asahii BZ901, Clinical isolates, Chongqing, China
Trichosporon asahii BZ902, Clinical isolates, Shanghai, China
Trichosporon domesticum CBS 8280
Trichosporon dermatis CBS 2043
Trichosporon jirovecii CBS 6864
Trichosporon mucoides CBS 7625
Trichosporon asteroides CBS 2481
Trichosporon coremiiforme CBS 2482
Trichosporon inkin CBS 5585
Trichosporon japonicum CBS 8641
Trichosporon lactis CBS 9051
Trichosporon ovoides CBS 7556
Trichosporon dohaense CBS 10761
Trichosporon faecale CBS 4828
Trichosporon debeurumanianum CBS 1896
Trichosporon montevideense CBS 8261
Cryptococcus gattii S8012, Clinical isolates, Shanghai, China
Cryptococcus laurentii CICC31237, CGMCC
Cryptococcus luteolus ATCC10671
Cryptococcus neoformans var. grubii H99, National Institutes of Health, USA
Cryptococcus neoformans var. neoformans Clinical isolates, Shanghai, China
Cryptococcus podzolicus CBS6819
Cryptococcus podzolicus Clinical isolates, Shanghai, China
Pichia pastoris Environmental isolates, Hubei, China
Candida albicans ATCC10231
Candida glabrata ATCC28226
Candida krusei ATCC2159
Candida parapsilosis ATCC90018
Candida parapsilosis Clinical isolates, Shanghai, China
Candida stellata ATCC10667
Candida tropicalis ATCC66029
Debaryomyces hansenii ATCC4144
Fonsecaea pedrosoi SCZ10025
Exophiala dermatitidis SCZ10002
Filobasidiella neoformans var. neoformans CBS7815
Sporothrix  schenckii SCZ10142
Acremonium chrysogenum ATCC20416
Aspergillus fumigatus SCZ10130
Aureobasidium pullulans Environmental isolates, Jiangsu, China

ATCC: American type culture collection, Rockville, MD, USA; CBS: Centraalbureau voor Schimmelcultures, Baarn, The Netherlands; SCZ: Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Changzheng Hospital, Shanghai, China; CGMCC: China General Microbiological Culture Collection Center, China.
2.2. DNA Extraction

For DNA extraction, two loopfuls of cultures grown on PDA agar (Oxoid Ltd., Basingstoke, Hampshire, England) for 2 to 5 days at 25°C were suspended in 500 μL of lysing buffer (50 mM Tris, 250 mM NaCl, 50 mM EDTA, 0.3% sodium dodecyl sulfate (SDS) (pH 8.0)) plus the equivalent of a 200 μL volume of 425 to 600 um diameter glass beads (Sigma). After being vortexed for 2 min, DNA was isolated using the DNAsecure Plant Kit (TIANGEN) according to the manufacturer’s protocol. We used a NanoDrop 2000 (Thermo Scientific, Rockford, IL) to quantify the DNA extracted from the CBS2479 strain (9.4 ng/μL) and then calculated the copy numbers (3.56 × 106 copies/μL) from the 24,271,268 kb full-length genome. DNA was serially diluted 1 : 10 up to 10−6-fold dilutions (9.4 ng/μL to 9.4 fg/μL), and 1 μL of each serial dilution was used as a template in the LAMP systems. DNA solutions could be kept for several months at −20°C without noticeable degradation.

2.3. Design of LAMP Primers

Five sets of four species-specific LAMP primers were designed based on the T. asahii identifiable target, the rRNA gene IGS1 region. The LAMP primers were designed using the PRIMEREXPLORER V4 software program (http://primerexplorer.jp). A forward inner primer (FIP) consisted of the complementary sequence of F1 (F1c) and F2, and a backward inner primer (BIP) consisted of B1c and B2. The outer primers F3 and B3 were required for initiation of the LAMP reaction. The sequences of each primer are shown in Table 2.


Primers nameSequence (5′-3′)

TA-19F3CTTGGTCTTTGCAGCTCCTA
TA-19B3GGGAGACAAGAGGTCTCTGG
TA-19FIPGAGGCTGAGGTCTCGATGTGATTTGTATGCTCACCGGTACAGAC
TA-19BIPCCGCCTACCTCTGAGGCCTTTTTCAGGGCGGTTGAGGACTA
TA-19LFAGAGCTGGCAGGCTTGG
TA-19LBCTGTCCAAAGGGGCCTGGT

2.4. LAMP Reaction

The reaction mixture concentrations of each component were as follows: 20 mM Tris-HCl (pH 8.8), 10 mM KCl, 10 mM (NH4)2SO4, 0.1% Triton X-100, 0.8 M betaine, 8 mM MgSO4, 1.4 mM dNTP, 8 U Bst DNA polymerase, 40 pmol FIP and BIP, 5 pmol F3 and B3, and 20 pmol LB and LF, with 1 μL of crude DNA extract as the template. A reaction mixture volume of 25 μL was incubated at a constant temperature of 65°C for approximately 60 min. Double distilled water was used as a negative control.

2.5. Analysis of LAMP Products

Real-time turbidity caused by the accumulation of magnesium pyrophosphate was monitored spectrophotometrically at 650 nm with the LA-320C Loopamp Realtime Turbidimeter (Eiken Chemical Co., Ltd., Tochigi, Japan). The results were analyzed with the LA-320C software package. The product was electrophoresed on an agarose gel in Tris-acetate-EDTA (TAE) buffer followed by staining with ethidium bromide. Amplified products were sequenced to show that they matched the expected nucleotide sequences. Positive amplification was shown by the specific ladder-like pattern on a UV transilluminator at 320 nm. For visualization of the positive reaction, a fluorescent detection reagent (FD; Eiken Chemical Co., Ltd. Tokyo, Japan) was added to the reaction mixture and a change of color was observed visually (transparent to green color), while those remaining orange were considered negative.

After the LAMP reactions, 1 μL of each product was used for 1% agarose gel electrophoresis (100 V, constant for 40 min). A Gel Doc XR+ imaging system (Bio-Rad, Hercules, CA) was used to observe the band patterns. The samples were considered positive if they showed a characteristic ladder-like band pattern.

2.6. PCR Assay

PCR assay was performed to compare the sensitivity with the established LAMP methods. The outer primers (F3 and B3) of LAMP assay were used for PCR assay. The 25 μL volume reaction mixture contained 1× PCR buffer (10 mM Tris–HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2), 0.2 mM each dNTP, 0.2 μM each primer (F3 and B3), 1 U Taq DNA polymerase (TaKaRa Biotechnology Co., Ltd., Dalian, China), and 5 μL template DNA. Each reaction was initially denatured at 95°C for 5 min; followed by 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s; and a final extension at 72°C for 3 min using a C1000 Thermal cycler (Bio-Rad Laboratories, Hercules, CA, USA). PCR products were separated on 1% (w/v) agarose gel in 1× TAE stained with EB and photographed using a GelDoc XR+ Imager (Bio-Rad, Hercules, CA).

2.7. Experimental Infection of T. asahii

Ten male BALB/c mice, 6–8 weeks old, were purchased from the laboratory animal research center of the China Academy of Chinese Medical Sciences and were housed in two cages, containing 5 mice each. Mice were provided with food and water. The mice in the infection model group received two intraperitoneal injections of 150 mg/kg cyclophosphamide (Jiangsu Hengrui Medicine Co., Ltd, Jiangsu, China) in sterile saline 2 days before and 1 day after fungal inoculation. On the day of infection, the mice in infection group were intravenously inoculated with 1 × 107 cfu/mouse of T. asahii in a 0.2 mL volume by injection into the lateral tail vein, and the mice in control group were not treated.

2.8. Evaluation of the LAMP Assay Using Experimental Animal and Clinical Samples

To evaluate the LAMP assay, blood, urine, and peritoneal irrigation fluid were collected from 5 experimentally infected mice and 5 control mice. The animal samples were tested by LAMP assay and conventional culture in parallel, and the human samples had been tested by API 20 C AUX systems (bioMérieux) before LAMP. All samples (Table 3) were transferred to Eppendorf tubes and centrifuged at 12,000 ×g for 5 min. The cells were resuspended in 100 μL of cell lysis buffer and boiled at 100°C for 5 min, and the supernatant DNA was extracted with DEXPATs (TaKaRa Biomedical, Inc., Otsu, Japan) according to the manufacturer’s instructions.


Sample numberSourceLAMPCultureAPI 20 C AUX systems

1Mouse, blood++
2Mouse, blood++
3Mouse, blood++
4Mouse, blood++
5Mouse, blood++
6Mouse, urine++
7Mouse, urine++
8Mouse, urine++
9Mouse, peritoneal irrigation fluid++
10Mouse, peritoneal irrigation fluid++
11Mouse, blood
12Mouse, blood
13Mouse, blood
14Mouse, blood
15Mouse, blood
16Human, blood+T. asahii
17Human, blood+T. asahii
18Human, blood+T. asahii
19Human, blood+T. asahii
20Human, blood+T. asahii
21Human, blood+T. asahii
22Human, bloodC. albicans
23Human, bloodC. albicans
24Human, bloodC. tropicalis
25Human, bloodC. albicans

3. Results

3.1. Primer and Temperature Selection for the LAMP Reaction

In this study, we designed 5 sets of primers for LAMP amplification. Among these primers, those for IGS-LAMP had the highest amplification rates and the shortest peak appearance times. We concluded that the TA-19 LAMP reaction primer combination is the best. To optimize the LAMP reaction temperature, we conducted the procedures under different conditions. LAMP assays had been performed under isothermal conditions between 59°C and 66°C. Considering the larger amounts of DNA amplicons and the optimal temperature for Bst DNA polymerase activity, we choose 65°C as the final reaction temperature (data does not show).

3.2. Specificity of the LAMP Reaction

To determine specificity of the primers, 51 isolates were also subjected to the LAMP assay. A Loopamp Realtime turbidimeter (LA-320C) was employed to detect the LAMP products in the LAMP assays. As shown in Figure 1(a), LAMP products were amplified only from DNA samples of T. asahii, and the typical time threshold curve indicating turbidity values was obtained, whereas other related Trichosporon strains (Figure 2(a)) and other fungal strains (Figure 2(c)) did not show increases in turbidity. No false positive amplification was observed, indicating the high specificity of the established LAMP assays. Amplification was completed within 1 h isothermally at 65°C in a water bath. The products of the LAMP reaction could be detected by electrophoresis on 1% agarose gels and showed ladder-like patterns (Figure 1(b)). The products were also visible in Eppendorf vials. Positive reactions underwent a color change to green, whereas negative reactions remained light orange (Figures 1(c), 2(b), and 2(d)).

3.3. Sensitivity of the LAMP Reaction

Tenfold serial dilutions of total genomic DNA from the T. asahii strain CBS2479 were used to test the sensitivity of the LAMP assay. The results indicated that the detection limit for the LAMP reaction was between 3.56 × 103 and 3.56 × 102 genome copies of template (Figures 3(a), 3(b), and 3(d)), while it was 3.56 × 104 genome copies for the PCR assay (Figure 3(c)). This suggested that the LAMP assay is 10 times more sensitive than the PCR assay.

3.4. Clinical Sample Detection

All samples from confirmed T. asahii-positive mice tested positive, whereas blood samples from unaffected mice tested negative (Table 2). After the patients with invasive trichosporonosis were proven by blood culture and the isolates were identified using the API 20C Aux yeast identification system, the blood samples were tested by the LAMP assay. The correlation between the LAMP assays and the culture and biochemical method results of the same tissue samples proved to be coincident.

4. Discussion

In this study, we reported on LAMP, a novel rapid detection method for identification of the pathogenic fungus Trichosporon asahii. An accurate and rapid diagnosis system for trichosporonosis caused by T. asahii is critical for early correct treatment. Trichosporonosis is a type of fungal infectious disease for which a series of PCR-based diagnostic systems has been developed [10]. Despite their simplicity and accuracy, PCR-based diagnostic methods are not widely used in clinics as routine diagnostic tools due to the need for a thermal cycler and the sequence analysis of DNA amplification products.

Compared with other PCR-based methods, LAMP is a powerful and innovative technique that provides a simple and rapid tool for early detection of infectious pathogens [22, 23]. A set of two inner primers and two outer primers are designed to recognize six distinct regions of the target DNA. The LAMP assay described in this paper is advantageous due to its simple operation, rapid reaction, and ease of detection. It can be conducted in 1 hour or less and is thus very fast. Even after including the time required to manipulate the sample and extract the DNA, the total assay duration is only approximately 3 hours. However, other common assays used in clinical identification, such as strain culturing and fungal identification by microscopy, the API 20 system, or rRNA gene PCR product sequencing, require 2 to 7 days to complete [16]. In contrast, the only equipment needed for the LAMP reaction is a standard laboratory water bath or a heating block that can provide a constant temperature.

In this study, we designed and compared additional primers based on different parts of IGS1 and used 15 different T. asahii strains, including different clinical strains isolated from Chinese patients, to confirm that our primers could accurately identify T. asahii clinical isolates. The LAMP primers in this study were designed from the intergenic spacer (IGS) 1 region of the rRNA gene. In contrast to ribosomal genes, which contain highly conserved sequences that are detected in close organisms, the intergenic spacer of rRNA (IGS) appears to be the most rapidly evolving spacer region. The IGS region displays higher polymorphism, which facilitates molecular identification. Both the conserved and the variable regions of IGS sequences are suitable for the development of PCR primers for pathogenic fungi. The data in this study show that our LAMP primer based on the IGS region is specific and could effectively identify T. asahii and differentiate it from other pathogenic fungi, especially other related pathogenic Trichosporon strains. Both Kohei and our study demonstrate the preferred choice of the IGS sequences for the molecular identification of closely related species.

To develop a detection system for T. asahii, we evaluated the sensitivity assay. LAMP amplifies DNA with high efficiency under isothermal conditions without a significant influence from the copresence of nontarget DNA. In this study, the LAMP method of detecting T. asahii was found to be highly sensitive, as it could detect levels of T. asahii up to genome copies fungal DNA per reaction, whereas, by PCR, the detection of T. asahii was possible only up to 3.56 * 104 genome copies of fungal DNA per reaction. This indicates that the sensitivity of LAMP is ten times higher than that of standard PCR. This increased sensitivity makes LAMP a better choice than PCR for the detection of T. asahii in cases where lower fungal concentrations are expected. The LAMP assay also successfully detects the presence of T. asahii among clinical samples.

Additionally, the LAMP assay produces a large amount of amplified product, resulting in easier detection by visual observation of an increase in turbidity caused by generation of magnesium pyrophosphate. SYBR green was used as an indirect method for the detection of positive reactions. SYBR green has been shown to not affect the LAMP reaction and can thus be added to the master mix before the DNA amplification step, therefore avoiding the need to open the tubes at the end of the reaction [22]. This is an important advantage over other visualization methods because the LAMP products are an important source of cross contamination [24]. The change in turbidity can also be measured quantitatively and in real-time by using a real-time turbidimeter [22]. The amplified product could be detected by a conventional approach of gel electrophoresis, but this method is easily contaminated and leads to false positives. In this study, there is no difference among the three methods. However, according to our knowledge, a turbidimeter is the better way to measure the product.

In summary, in the current study, we showed that the LAMP technique based on the IGS region enables specific detection of T. asahii but excludes related Trichosporon species and other pathogenic fungi. It is a novel technique that can potentially be used for rapid diagnosis of T. asahii infections, not only in laboratories but also in an outpatient clinic setting. The method can be applied not only to cultures but also to a variety of clinical samples. This can be of great significance for detecting organisms that cause invasive or disseminated infections but are difficult to cultivate from the samples, such as the zygomycete species. In conclusion, the LAMP method described in this study represents a new, sensitive, specific, and rapid protocol for the detection of T. asahii.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Jianfeng Zhou and Yong Liao contributed equally to this work and should be considered co-first authors.

Acknowledgments

The authors would like to thank Dr. Chen Min (Shanghai Key Laboratory of Molecular Medical Mycology, Institute of Dermatology and Mycosis of Changzheng Hospital, Second Military Medical University, China) for his professional suggestion and contribution in DNA samples of control strains, and Professor Chen Yu-cong (Department of Dermatology, Shanghai Huashan Hospital, Fudan University, China) for clinical samples of invasive trichosporonosis. Additionally, this study was funded by grants from National Natural Science Foundation of China (no. 81301410) and the Twelfth Five-Year Plan Key Program of Foundation of China PLA (no.BWS11J059).

References

  1. T. C. Chagas-Neto, G. M. Chaves, and A. L. Colombo, “Update on the genus Trichosporon,” Mycopathologia, vol. 166, no. 3, pp. 121–132, 2008. View at: Publisher Site | Google Scholar
  2. S. Takamura, T. Oono, H. Kanzaki, and J. Arata, “Disseminated Trichosporonosis with Trichosporon asahii,” European Journal of Dermatology, vol. 9, no. 7, pp. 577–579, 1999. View at: Google Scholar
  3. T. Itoh, H. Hosokawa, U. Kohdera, N. Toyazaki, and Y. Asada, “Disseminated infection with Trichosporon asahii,” Mycoses, vol. 39, no. 5-6, pp. 195–199, 1996. View at: Publisher Site | Google Scholar
  4. Y. Nishiura, K. Nakagawa-Yoshida, M. Suga, T. Shinoda, E. Guého, and M. Ando, “Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis,” Journal of Medical and Veterinary Mycology, vol. 35, no. 1, pp. 45–52, 1997. View at: Publisher Site | Google Scholar
  5. T. Tashiro, H. Nagai, H. Nagaoka, Y. Goto, P. Kamberi, and M. Nasu, “Trichosporon beigelii pneumonia in patients with hematologic malignancies,” Chest, vol. 108, no. 1, pp. 190–195, 1995. View at: Publisher Site | Google Scholar
  6. M. L. Moretti-Branchini, K. Fukushima, A. Z. Schreiber et al., “Trichosporon species infection in bone marrow transplanted patients,” Diagnostic Microbiology and Infectious Disease, vol. 39, no. 3, pp. 161–164, 2001. View at: Publisher Site | Google Scholar
  7. J. R. Ebright, M. R. Fairfax, and J. A. Vazquez, “Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia,” Clinical Infectious Diseases, vol. 33, no. 5, pp. E28–30, 2001. View at: Publisher Site | Google Scholar
  8. S. A. Ghiasian, A. H. Maghsood, and S. H. Mirhendi, “Disseminated, fatal Trichosporon asahii infection in a bone marrow transplant recipient,” Journal of Microbiology, Immunology and Infection, vol. 39, no. 5, pp. 426–429, 2006. View at: Google Scholar
  9. M. S. Biasoli, D. Carlson, G. J. Chiganer et al., “Systemic infection caused by Trichosporon asahii in a patient with liver transplant,” Medical Mycology, vol. 46, no. 7, pp. 719–723, 2008. View at: Publisher Site | Google Scholar
  10. A. L. Colombo, A. C. B. Padovan, and G. M. Chaves, “Current knowledge of Trichosporon spp. and trichosporonosis,” Clinical Microbiology Reviews, vol. 24, no. 4, pp. 682–700, 2011. View at: Publisher Site | Google Scholar
  11. M. H. Miceli, J. A. Díaz, and S. A. Lee, “Emerging opportunistic yeast infections,” The Lancet Infectious Diseases, vol. 11, no. 2, pp. 142–151, 2011. View at: Publisher Site | Google Scholar
  12. D. Vázquez-González, A. M. Perusquía-Ortiz, M. Hundeiker, and A. Bonifaz, “Opportunistic yeast infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis,” Journal der Deutschen Dermatologischen Gesellschaft, vol. 11, no. 5, pp. 381–395, 2013. View at: Publisher Site | Google Scholar
  13. J. A. Ribes, C. L. Vanover-Sams, and D. J. Baker, “Zygomycetes in human disease,” Clinical Microbiology Reviews, vol. 13, no. 2, pp. 236–301, 2000. View at: Publisher Site | Google Scholar
  14. M. A. Pfaller, D. J. Diekema, D. L. Gibbs et al., “Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing,” Journal of Clinical Microbiology, vol. 45, no. 6, pp. 1735–1745, 2007. View at: Publisher Site | Google Scholar
  15. S. J. Bajwa and A. Kulshrestha, “Fungal infections in intensive care unit: challenges in diagnosis and management,” Annals of Medical and Health Sciences Research, vol. 3, no. 2, pp. 238–244, 2013. View at: Publisher Site | Google Scholar
  16. M. C. Arendrup, T. Boekhout, M. Akova et al., “ESCMID and ECMM joint clinical gui delines for the diagnosis and management of rare invasive yeast infections,” Clinical Microbiology and Infection, vol. 20, supplement 3, pp. 76–98, 2014. View at: Google Scholar
  17. J. O. Silva, S. A. Franceschini, M. A. S. Lavrador, and R. C. Candido, “Performance of selective and differential media in the primary isolation of yeasts from different biological samples,” Mycopathologia, vol. 157, no. 1, pp. 29–36, 2004. View at: Publisher Site | Google Scholar
  18. S. Hirschi, V. Letscher-Bru, J. Pottecher et al., “Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient,” Journal of Clinical Microbiology, vol. 50, no. 12, pp. 4168–4170, 2012. View at: Publisher Site | Google Scholar
  19. M. Sano, M. Sugitani, T. Ishige et al., “Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis,” Virchows Archiv, vol. 451, no. 5, pp. 929–935, 2007. View at: Publisher Site | Google Scholar
  20. M. Xiao, L.-N. Guo, F. Kong et al., “Practical identification of eight medically important Trichosporon species by reverse line blot hybridization (RLB) assay and rolling circle amplification (RCA),” Medical Mycology, vol. 51, no. 3, pp. 300–308, 2013. View at: Publisher Site | Google Scholar
  21. T. Notomi, H. Okayama, H. Masubuchi et al., “Loop-mediated isothermal amplification of DNA,” Nucleic Acids Research, vol. 28, no. 12, article E63, 2000. View at: Publisher Site | Google Scholar
  22. J. Zhang, J. Zhu, H. Ren et al., “Rapid visual detection of highly pathogenic Streptococcus suis serotype 2 isolates by use of loop-mediated isothermal amplification,” Journal of Clinical Microbiology, vol. 51, no. 10, pp. 3250–3256, 2013. View at: Publisher Site | Google Scholar
  23. J. Zhang, J. Zhu, Y. Feng et al., “Rapid and sensitive detection of H7N9 avian influenza virus by use of reverse transcription-loop-mediated isothermal amplification,” Journal of Clinical Microbiology, vol. 51, no. 11, pp. 3760–3764, 2013. View at: Publisher Site | Google Scholar
  24. L. Niessen and R. F. Vogel, “Detection of Fusarium graminearum DNA using a loop-mediated isothermal amplification (LAMP) assay,” International Journal of Food Microbiology, vol. 140, no. 2-3, pp. 183–191, 2010. View at: Publisher Site | Google Scholar

Copyright © 2015 Jianfeng Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1258 Views | 485 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.